The estrogen receptor: Two or more molecules, multiple variants, diverse localizations, signaling and functions. Are we undergoing a paradigm-shift as regards their significance in breast cancer?

Hormones

Volumn 12, Issue 1, 2013, Pages 69-85

  Kampa, Marilena ^a   Pelekanou, Vassiliki ^a   Notas, George ^a   Stathopoulos, Efstathios N ^a   Castanas, Elias ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Cancer; Estrogen receptor; Nuclear extranuclear actions; Pathology; Receptor isoforms; Signaling

Indexed keywords

ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR 30; GROWTH FACTOR RECEPTOR;

BREAST CANCER; CANCER GROWTH; CELL MEMBRANE; DISEASE ASSOCIATION; HUMAN; ION TRANSPORT; PALMITOYLATION; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 84876231060     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401288     Document Type: Review

References (211)

1. Germain P, Staels B, Dacquet C, Spedding M, Laudet V, 2006 Overview of nomenclature of nuclear receptors. Pharmacol Rev 58: 685-704.
2. Thomas C, Gustafsson JA, 2011 The different roles of ER subtypes in cancer biology and therapy. Nat Rev Cancer 11: 597-608.
3. Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J, 1986 Sequence and expression of human estrogen receptor complementary DNA. Science 231: 1150-1154.
4. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA, 1996 Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93: 5925-5930.
5. Dahlman-Wright K, Cavailles V, Fuqua SA, et al, 2006 International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacol Rev 58: 773-781.
6. Nilsson S, Makela S, Treuter E, et al, 2001 Mechanisms of estrogen action. Physiol Rev 81: 1535-1565.
7. Chang CS, Kokontis J, Liao ST, 1988 Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc Natl Acad Sci USA 85: 7211-7215.
8. Wang Z, Zhang X, Shen P, Loggie BW, Chang Y, Deuel TF, 2005 Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66. Biochem Biophys Res Commun 336: 1023-1027.
9. Flouriot G, Brand H, Denger S, et al, 2000 Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1. EMBO J 19: 4688-4700.
10. Wang Z, Zhang X, Shen P, Loggie BW, Chang Y, Deuel TF, 2006 A variant of estrogen receptor-α, hER-α36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling. Proc Natl Acad Sci U S A 103: 9063-9068.
11. Kos M, O'Brien S, Flouriot G, Gannon F, 2000 Tissuespecific expression of multiple mRNA variants of the mouse estrogen receptor alpha gene. FEBS Lett 477: 15-20.
12. Li L, Haynes MP, Bender JR, 2003 Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells. Proc Natl Acad Sci USA 100: 4807-4812.
13. Hisamoto K, Bender JR, 2005 Vascular cell signaling by membrane estrogen receptors. Steroids 70: 382-387.
14. Kim KH, Bender JR, 2009 Membrane-initiated actions of estrogen on the endothelium. Mol Cell Endocrinol 308: 3-8.
15. Kim KH, Toomre D, Bender JR, 2011 Splice isoform estrogen receptors as integral transmembrane proteins. Mol Biol Cell 22: 4415-4423.
16. Kang L, Zhang X, Xie Y, et al, 2010 Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling. Mol Endocrinol 24: 709-721.
17. Fuqua SA, Schiff R, Parra I, et al, 1999 Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer. Cancer Res 59: 5425-5428.
18. Saji S, Omoto Y, Shimizu C, et al, 2002 Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)--positive breast cancer: specific correlation with progesterone receptor. Cancer Res 62: 4849-4853.
19. Ramsey TL, Risinger KE, Jernigan SC, Mattingly KA, Klinge CM, 2004 Estrogen receptor beta isoforms exhibit differences in ligand-activated transcriptional activity in an estrogen response element sequence-dependent manner. Endocrinology 145: 149-160.
20. Leung YK, Mak P, Hassan S, Ho SM, 2006 Estrogen receptor (ER)-beta isoforms: a key to understanding ER-beta signaling. Proc Natl Acad Sci U S A 103: 13162-13167.
21. Leung YK, Lee MT, Lam HM, Tarapore P, Ho SM, 2012 Estrogen receptor-beta and breast cancer: translating biology into clinical practice. Steroids 77: 727-737.
22. Saville B, Wormke M, Wang F, et al, 2000 Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements. J Biol Chem 275: 5379-5387.
23. Kushner PJ, Agard D, Feng WJ, et al, 2000 Oestrogen receptor function at classical and alternative response elements. Novartis Found Symp 230: 20-6; discussion 7-40.
24. Kushner PJ, Agard DA, Greene GL, et al, 2000 Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 74: 311-317.
25. Hall JM, Couse JF, Korach KS, 2001 The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 276: 36869-36872.
26. Kato S, Endoh H, Masuhiro Y, et al, 1995 Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270: 1491-1494.
27. Shim WS, Conaway M, Masamura S, et al, 2000 Estradiol hypersensitivity and mitogen-activated protein kinase expression in long-term estrogen deprived human breast cancer cells in vivo. Endocrinology 141: 396-405.
28. Coutts AS, Murphy LC, 1998 Elevated mitogen-activated protein kinase activity in estrogen-nonresponsive human breast cancer cells. Cancer Res 58: 4071-4074.
29. Razandi M, Pedram A, Rosen EM, Levin ER 2004 BRCA1 inhibits membrane estrogen and growth factor receptor signaling to cell proliferation in breast cancer. Mol Cell Biol 24: 5900-5913.
30. Razandi M, Pedram A, Merchenthaler I, Greene GL, Levin ER, 2004 Plasma membrane estrogen receptors exist and functions as dimers. Mol Endocrinol 18: 2854-2865.
31. Hammes SR, Levin ER, 2011 Minireview: Recent advances in extranuclear steroid receptor actions. Endocrinology 152: 4489-4495.
32. Deecher DC, Swiggard P, Frail DE, O'Connor LT, 2003 Characterization of a membrane-associated estrogen receptor in a rat hypothalamic cell line (D12). Endocrine 22: 211-223.
33. Zhang J, Li G, Li Z, et al, 2012 Estrogen-independent effects of ER-α36 in ER-negative breast cancer. Steroids 77: 663-673.
34. Moriarty K, Kim KH, Bender JR, 2006 Minireview: estrogen receptor-mediated rapid signaling. Endocrinology 147: 5557-5563.
35. Kampa M, Notas G, Pelekanou V, et al, 2012 Early membrane initiated transcriptional effects of estrogens in breast cancer cells: First pharmacological evidence for a novel membrane estrogen receptor element (ERx). Steroids 77: 959-967.
36. 2+] i in female rat distal colon. Mol Cell Endocrinol 199: 87-103.
37. Condliffe SB, Doolan CM, Harvey BJ, 2001 17betaoestradiol acutely regulates Cl- secretion in rat distal colonic epithelium. J Physiol 530: 47-54.
38. Heldring N, Pike A, Andersson S, et al, 2007 Estrogen receptors: how do they signal and what are their targets. Physiol Rev 87: 905-931.
39. Acconcia F, Ascenzi P, Bocedi A, et al, 2005 Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol. Mol Biol Cell 16: 231-237.
40. Marino M, Ascenzi P, Acconcia F, 2006 S-palmitoylation modulates estrogen receptor alpha localization and functions. Steroids 71: 298-303.
41. Smotrys JE, Linder ME, 2004 Palmitoylation of intracellular signaling proteins: regulation and function. Annu Rev Biochem 73: 559-587.
42. Schlesinger MJ, Magee AI, Schmidt MF 1980 Fatty acid acylation of proteins in cultured cells. J Biol Chem 255: 10021-10024.
43. Martin BR, Wang C, Adibekian A, Tully SE, Cravatt BF, 2012 Global profiling of dynamic protein palmitoylation. Nat Methods 9: 84-89.
44. Resh MD, 2006 Palmitoylation of ligands, receptors, and intracellular signaling molecules. Sci STKE 2006: re14.
45. Acconcia F, Bocedi A, Ascenzi P, Marino M, 2003 Does palmitoylation target estrogen receptors to plasma membrane caveolae? IUBMB Life 55: 33-35.
46. Galluzzo P, Ascenzi P, Bulzomi P, Marino M, 2008 The nutritional flavanone naringenin triggers antiestrogenic effects by regulating estrogen receptor alphapalmitoylation. Endocrinology 149: 2567-2575.
47. Pedram A, Razandi M, Deschenes RJ, Levin ER, 2012 DHHC-7 and -21 are palmitoylacyltransferases for sex steroid receptors. Mol Biol Cell 23: 188-199.
48. Pedram A, Razandi M, Sainson RC, Kim JK, Hughes CC, Levin ER, 2007 A conserved mechanism for steroid receptor translocation to the plasma membrane. J Biol Chem 282: 22278-22288.
49. Song RX, Barnes CJ, Zhang Z, Bao Y, Kumar R, Santen RJ, 2004 The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane. Proc Natl Acad Sci U S A 101: 2076-2081.
50. Galluzzo P, Caiazza F, Moreno S, Marino M, 2007 Role of ERbeta palmitoylation in the inhibition of human colon cancer cell proliferation. Endocr Relat Cancer 14: 153-167.
51. Marino M, Ascenzi P, 2006 Steroid hormone rapid signaling: the pivotal role of S-palmitoylation. IUBMB Life 58: 716-719.
52. Hammes SR, Levin ER, 2007 Extranuclear steroid receptors: nature and actions. Endocr Rev 28: 726-741.
53. Acconcia F, Marino M, 2011 The Effects of 17betaestradiol in Cancer are Mediated by Estrogen Receptor Signaling at the Plasma Membrane. Front Physiol 2: 30.
54. Galluzzo P, Rastelli C, Bulzomi P, Acconcia F, Pallottini V, Marino M, 2009 17beta-Estradiol regulates the first steps of skeletal muscle cell differentiation via ER-alpha-mediated signals. Am J Physiol Cell Physiol 297: C1249-1262.
55. Filardo EJ, Quinn JA, Frackelton AR, Jr, Bland KI, 2002 Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMPmediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 16: 70-84.
56. Filardo EJ, Thomas P, 2012 Mini review: G Protein-- Coupled Estrogen Receptor-1, GPER-1: Its Mechanism of Action and Role in Female Reproductive Cancer, Renal and Vascular Physiology. Endocrinology 153: 2953-2962.
57. Filardo EJ, Thomas P, 2005 GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol Metab 16: 362-367.
58. Filardo E, Quinn J, Pang Y, et al, 2007 Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology 148: 3236-45
59. Thomas P, Pang Y, Filardo EJ, Dong J 2005 Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146: 624-632.
60. Langer G, Bader B, Meoli L, et al, 2010 A critical review of fundamental controversies in the field of GPR30 research. Steroids 75: 603-610.
61. Prossnitz ER, Barton M, 2011 The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocrinol 7: 715-726.
62. Cheng SB, Graeber CT, Quinn JA, Filardo EJ, 2011 Retrograde transport of the transmembrane estrogen receptor, G-protein-coupled-receptor-30 (GPR30/GPER) from the plasma membrane towards the nucleus. Steroids 76: 892-896.
63. Cheng SB, Quinn JA, Graeber CT, Filardo EJ, 2011 Down-modulation of the G-protein-coupled estrogen receptor, GPER, from the cell surface occurs via a trans-Golgi-proteasome pathway. J Biol Chem 286: 22441-22455.
64. Nilsson BO, Olde B, Leeb-Lundberg LM, 2011 G protein-coupled oestrogen receptor 1 (GPER1)/GPR30: a new player in cardiovascular and metabolic oestrogenic signalling. Br J Pharmacol 163: 1131-1139.
65. Levin ER, 2009 G protein-coupled receptor 30: estrogen receptor or collaborator? Endocrinology 150: 1563-1565.
66. Notas G, Kampa M, Pelekanou V, Castanas E, 2011 Interplay of estrogen receptors and GPR30 for the regulation of early membrane initiated transcriptional effects: A pharmacological approach. Steroids 77: 943-950.
67. Heberden C, Reine F, Grosse B, et al, 2006 Detection of a raft-located estrogen receptor-like protein distinct from ER alpha. Int J Biochem Cell Biol 38: 376-391.
68. Harrington WR, Kim SH, Funk CC, et al, 2006 Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action. Mol Endocrinol 20: 491-502.
69. Madak-Erdogan Z, Kieser KJ, Kim SH, Komm B, Katzenellenbogen JA, Katzenellenbogen BS, 2008 Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors. Mol Endocrinol 22: 2116-2127.
70. Toran-Allerand CD, Guan X, MacLusky NJ, et al, 2002 ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J Neurosci 22: 8391-401
71. Piccart MJ, Trivedi S, Maaroufi Y, Debbaudt A, Veenstra S, Leclercq G, 1998 Evolution towards hormone independence of the MXT mouse mammary tumor is associated with a gradual change in its estrogen receptor molecular polymorphism. Cancer Biochem Biophys 16: 169-182.
72. Sheridan PJ, Buchanan JM, Anselmo VC, Martin PM, 1979 Equilibrium: the intracellular distribution of steroid receptors. Nature 282: 579-582.
73. Edwards DP, Martin PM, Horwitz KB, Chamness GC, McGuire WL, 1980 Subcellular compartmentalization of estrogen receptors in human breast cancer cells. Exp Cell Res 127: 197-213.
74. Yamashita S, 1998 Localization and functions of steroid hormone receptors. Histol Histopathol 13: 255-270.
75. Hager GL, Lim CS, Elbi C, Baumann CT, 2000 Trafficking of nuclear receptors in living cells. J Steroid Biochem Mol Biol 74: 249-254.
76. Dauvois S, White R, Parker MG, 1993 The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J Cell Sci 106: 1377-1388.
77. Sebastian T, Sreeja S, Thampan RV, 2004 Import and export of nuclear proteins: focus on the nucleocytoplasmic movements of two different species of mammalian estrogen receptor. Mol Cell Biochem 260: 91-102.
78. Fornerod M, Ohno M, Yoshida M, Mattaj IW, 1997 CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90: 1051-1060.
79. DeFranco DB 2001 Nuclear export: DNA-binding domains find a surprising partner. Curr Biol 11: R1036-1037.
80. Nonclercq D, Journe F, Laios I, et al, 2007 Effect of nuclear export inhibition on estrogen receptor regulation in breast cancer cells. J Mol Endocrinol 39: 105-118.
81. Castoria G, Migliaccio A, Auricchio F, 2009 Signalingdependent nuclear export of estradiol receptor controls cell cycle progression in breast cancer cells. Mol Cell Endocrinol 308: 26-31.
82. Leclercq G, Lacroix M, Laios I, Laurent G, 2006 Estrogen receptor alpha: impact of ligands on intracellular shuttling and turnover rate in breast cancer cells. Curr Cancer Drug Targets 6: 39-64.
83. Laios I, Journe F, Nonclercq D, et al, 2005 Role of the proteasome in the regulation of estrogen receptor alpha turnover and function in MCF-7 breast carcinoma cells. J Steroid Biochem Mol Biol 94: 347-359.
84. Laios I, Journe F, Laurent G, et al, 2003 Mechanisms governing the accumulation of estrogen receptor alpha in MCF-7 breast cancer cells treated with hydroxytamoxifen and related antiestrogens. J Steroid Biochem Mol Biol 87: 207-221.
85. Reid G, Hubner MR, Metivier R, et al, 2003 Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol Cell 11: 695-707.
86. Rodriguez AL, Tamrazi A, Collins ML, Katzenellenbogen JA, 2004 Design, synthesis, and in vitro biological evaluation of small molecule inhibitors of estrogen receptor alpha coactivator binding. J Med Chem 47: 600-611.
87. Carlberg C, Seuter S, 2010 Dynamics of nuclear receptor target gene regulation. Chromosoma 119: 479-484.
88. Govind AP, Thampan RV, 2001 Proteins interacting with the mammalian estrogen receptor: proposal for an integrated model for estrogen receptor mediated regulation of transcription. J Cell Biochem 80: 571-579.
89. Edwards DP, 2000 The role of coactivators and corepressors in the biology and mechanism of action of steroid hormone receptors. J Mammary Gland Biol Neoplasia 5: 307-24
90. Lieberman BA, 1997 The estrogen receptor activity cycle: dependence on multiple protein-protein interactions. Crit Rev Eukaryot Gene Expr 7: 43-59.
91. Savkur RS, Burris TP, 2004 The coactivator LXXLL nuclear receptor recognition motif. J Pept Res 63: 207-212.
92. Jacquot Y, Laios I, Cleeren A, et al, 2007 Synthesis, structure, and estrogenic activity of 4-amino-3-(2--methylbenzyl)coumarins on human breast carcinoma cells. Bioorg Med Chem 15: 2269-2282.
93. Metzger D, Ali S, Bornert JM, Chambon P, 1995 Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells. J Biol Chem 270: 9535-9542.
94. Houtman R, de Leeuw R, Rondaij M, et al, 2012 Serine-305 Phosphorylation Modulates Estrogen Receptor Alpha Binding to a Coregulator Peptide Array, with Potential Application in Predicting Responses to Tamoxifen. Mol Cancer Ther 11: 805-816.
95. Leduc AM, Trent JO, Wittliff JL, et al, 2003 Helixstabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactions. Proc Natl Acad Sci U S A 100: 11273-8
96. Willmer EN, 1961 Steroids and cell surfaces. Biol Rev Camb Philos Soc 36: 368-398.
97. Seyle H, 1952 Correlation between the chemicalstructure and the pharmacological actions of steroid. Endocrinology 30: 437-453.
98. Szego CM, Davis JS, 1967 Adenosine 3',5'-monophosphate in rat uterus: acute elevation by estrogen. Proc Natl Acad Sci USA 58: 1711-1718.
99. Milgrom E, Atger M, Baulieu EE, 1973 Studies on estrogen entry into uterine cells and on estradiol-receptor complex attachment to the nucleus-is the entry of estrogen into uterine cells a protein-mediated process? Biochim Biophys Acta 320: 267-283.
100. Harrison RW, Fairfield S, Orth DN, 1974 Evidence for glucocorticoid transport through the target cell membrane. Biochem Biophys Res Commun 61: 1262-1267.
101. Suyemitsu T, Terayama H, 1975 Specific binding sites for natural glucocorticids in plasma membranes of rat liver. Endocrinology 96: 1499-1508.
102. Pietras RJ, Szego CM, 1977 Specific binding sites of estrogen at the outer surface of isolated endometrial cells. Nature 265: 69-72.
103. Baulieu E, 1978 Cell membrane a target for steroid hormone. Mol Cell Endocrinol 12: 247-254.
104. Muller RE, Johnston TC, Traish AM, Wotiz HH, 1979 Studies on the mechanism of estradiol uptake by rat uterine cells and on estradiol binding to uterine plasma membranes. Adv Exp Med Biol 117: 401-421.
105. Nenci I, Fabris G, Marchetti E, Marzola A 1980 Cytochemical evidence for steroid binding sites in the plasma membrane of target cells. In: Bresciani F, (ed) Perspectives in Steroid Receptor Reasearch. New York: Raven Press.
106. Pietras RJ, Szego CM, 1980 Partial purification and characterization of oestrogen receptors in subfractions of hepatocyte plasma membranes. Biochem J 191: 743-760.
107. Schaeffer JM, Stevens S, Smith RG, Hsueh AJ, 1980 Binding of 2-hydroxyestradiol to rat anterior pituitary cell membranes. J Biol Chem 255: 9838-9843.
108. Giorgi EP, Stein WD 1981 The transport of steroids into animal cells in culture. Endocrinology 108: 688-697.
109. Zanker KS, Prokscha GW, Blumel G, 1981 Plasma membrane-integrated estrogen receptors in breast tissue: possible modulator molecular for intracellular hormone level. J Cancer Res Clin Oncol 100: 135-148.
110. Srivastava AK, Dey SB, Roy SK, 1983 Interaction of cyproterone acetate with sex hormone binding globulin of monkey plasma. Exp Clin Endocrinol 82: 232-234.
111. Diez A, Sancho MJ, Egana M, Trueba M, Marino A, Macarull JM, 1984 An interaction of testosterone with cell membranes. Horm Metab Res 16: 475-477.
112. Hryb DJ, Khan MS, Rosner W, 1985 Testosteroneestradiol-binding globulin binds to human prostatic cell membranes. Biochem Biophys Res Commun 128: 432-440.
113. Berthois Y, Pourreau-Schneider N, Gandilhon P, Mittre H, Tubiana N, Martin PM, 1986 Estradiol membrane binding sites on human breast cancer cell lines. Use of a fluorescent estradiol conjugate to demonstrate plasma membrane binding systems. J Steroid Biochem 25: 963-972.
114. Pourreau-Schneider N, Berthois Y, Gandilhon P, Cau P, Martin PM, 1986 Early alterations at the plasma membrane of breast cancer cell lines in response to estradiol and hydroxytamoxifen. Mol Cell Endocrinol 48: 77-88.
115. Tubiana N, Mishal Z, le Caer F, et al, 1986 Quantification of oestradiol binding at the surface of human lymphocytes by flow cytofluorimetry. Br J Cancer 54: 501-504.
116. Warner M, Gustafsson JA, 2006 Nongenomic effects of estrogen: why all the uncertainty? Steroids 71: 91-95.
117. Kampa M, Castanas E, 2006 Membrane steroid receptor signaling in normal and neoplastic cells. Mol Cell Endocrinol 246: 76-82.
118. Nakajima T, Kitazawa T, Hamada E, Hazama H, Omata M, Kurachi Y, 1995 17beta-Estradiol inhibits the voltage-dependent L-type Ca2+ currents in aortic smooth muscle cells. Eur J Pharmacol 294: 625-635.
119. Alexaki VI, Charalampopoulos I, Kampa M, et al, 2004 Estrogen exerts neuroprotective effects via membrane estrogen receptors and rapid Akt/NOS activation. FASEB J 18: 1594-1596.
120. Nadal A, Ropero AB, Fuentes E, Soria B, Ripoll C, 2004 Estrogen and xenoestrogen actions on endocrine pancreas: from ion channel modulation to activation of nuclear function. Steroids 69: 531-536.
121. Raz L, Khan MM, Mahesh VB, Vadlamudi RK, Brann DW, 2008 Rapid estrogen signaling in the brain. Neurosignals 16: 140-153.
122. Leclercq G, 2012 Calcium-induced activation of estrogen receptor alpha - New insight. Steroids: 77: 924-927.
123. Yang X, Chen G, Papp R, Defranco DB, Zeng F, Salama Gm 2012 Oestrogen upregulates L-type Ca(2) (+) channels via oestrogen-receptor- by a regional genomic mechanism in female rabbit hearts. J Physiol 590: 493-508.
124. Kelly MJ, Ronnekleiv OK, Ibrahim N, Lagrange AH, Wagner EJM, 2002 Estrogen modulation of K(+) channel activity in hypothalamic neurons involved in the control of the reproductive axis. Steroids 67: 447-456.
125. Kelly MJ, Qiu J, Wagner EJ, Ronnekleiv OK, 2002 Rapid effects of estrogen on G protein-coupled receptor activation of potassium channels in the central nervous system (CNS). J Steroid Biochem Mol Biol 83: 187-193.
126. Andersen HK, Urbach V, Van Kerkhove E, Prosser E, Harvey BJ, 1995 Maxi K+ channels in the basolateral membrane of the exocrine frog skin gland regulated by intracellular calcium and pH. Pflugers Arch 431: 52-65.
127. Muchekehu RW, Harvey BJ, 2009 Estradiol rapidly induces the translocation and activation of the intermediate conductance calcium activated potassium channel in human eccrine sweat gland cells. Steroids 74: 212-217.
128. Donnellan F, Keating N, Geoghegan P, Murray FE, Harvey BJ, Keely SJ, 2010 JNK mitogen-activated protein kinase limits calcium-dependent chloride secretion across colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 298: G37-44.
129. Alzamora R, O'Mahony F, Bustos V, et al, 2011 Sexual dimorphism and oestrogen regulation of KCNE3 expression modulates the functional properties of KCNQ1 K(+) channels. J Physiol 589: 5091-5107.
130. O'Mahony F, Alzamora R, Betts V, et al, 2007 Female gender-specific inhibition of KCNQ1 channels and chloride secretion by 17beta-estradiol in rat distal colonic crypts. J Biol Chem 282: 24563-24573.
131. Saint-Criq V, Rapetti-Mauss R, Yusef YR, Harvey BJ, 2012 Estrogen regulation of epithelial ion transport: Implications in health and disease. Steroids 77: 918-923.
132. Sirotkin AV, Mlyncek J, Lavrincik J, Bulla J, Hetenyi L, 1995 The ability of steroid hormones to control cAMP and cGMP production by human granulosa cells in culture. Cell Signal 7: 61-65.
133. Schreiber V, Nedvidkova J, Jahodova J, 1993 Anterior pituitary weight, cAMP, cGMP and prolactin levels after combined treatment with estradiol and methylene blue. Physiol Res 42: 171-174.
134. Lacasa D, Agli B, Giudicelli Y, 1992 Hormonal activation of the cGMP-inhibited low-Km cyclic AMP phosphodiesterase of rat adipocytes from different sites: influence of ovariectomy. Biochim Biophys Acta 1136: 99-104.
135. Minami T, Oomura Y, Nabekura J, Fukuda A, 1990 17 beta-estradiol depolarization of hypothalamic neurons is mediated by cyclic AMP. Brain Res 519: 301-307.
136. Levin ER, Frank HJ, Chaudhari A, Kirschenbaum MA, Bandt A, Mills S, 1989 Decreased atrial natriuretic factor receptors and impaired cGMP generation in glomeruli from the cardiomyopathic hamster. Biochem Biophys Res Commun 159: 807-814.
137. Sanchez-Bueno A, Sancho MJ, Trueba M, Macarulla JM, 1987 An early effect of estradiol at hepatic level, previous to its protein synthesis activation. Int J Biochem 19: 93-96.
138. Fleming H, Blumenthal R, Gurpide E, 1984 Characteristics of cyclic nucleotide dependent regulation of cytoplasmic E2 binders in cultured endometrial and breast cells. J Steroid Biochem 20: 5-9.
139. Flandroy L, Cheung WY, Steiner AL, 1983 Immunofluorescent localization of cGMP, cGMP-dependent protein kinase, calmodulin and cAMP in the rat uterus. Effects of estrogen treatment. Cell Tissue Res 233: 639-646.
140. Flandroy L, Galand P, 1978 Changes in cGMP and cAMP content in the estrogen-stimulated rat uterus: temporal relationship with other parameters of hormonal stimulation. J Cyclic Nucleotide Res 4: 145-58.
141. Flandroy L, Galand P, 1975 Oestrogen-related changes in uterine and vaginal cAMP and cGMP. Arch Int Physiol Biochim 83: 965-967.
142. Aronica SM, Kraus WL, Katzenellenbogen BS, 1994 Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci U S A 91: 8517-8521.
143. Aronica SM, Katzenellenbogen BS, 1991 Progesterone receptor regulation in uterine cells: stimulation by estrogen, cyclic adenosine 3',5'-monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors. Endocrinology 128: 2045-2052.
144. Thomas P, 2012 Rapid steroid hormone actions initiated at the cell surface and the receptors that mediate them with an emphasis on recent progress in fish models. Gen Comp Endocrinol 175: 367-383.
145. Alexaki VI, Charalampopoulos I, Kampa M, et al, 2006 Activation of membrane estrogen receptors induce pro-survival kinases. J Steroid Biochem Mol Biol 98: 97-110.
146. Szego EM, Barabas K, Balog J, et al, 2006 Estrogen induces estrogen receptor alpha-dependent cAMP response element-binding protein phosphorylation via mitogen activated protein kinase pathway in basal forebrain cholinergic neurons in vivo. J Neurosci 26: 4104-4110.
147. Makarevich AV, Sirotkin AV, Genieser HG, 2004 Action of protein kinase A regulators on secretory activity of porcine granulosa cells in vitro. Anim Reprod Sci 81: 125-136.
148. Shingo AS, Kito S, 2002 Estrogen induces elevation of cAMP-dependent protein kinase activity in immortalized hippocampal neurons: imaging in living cells. J Neural Transm 109: 171-174.
149. Carlstrom L, Ke ZJ, Unnerstall JR, Cohen RS, Pandey SC, 2001 Estrogen modulation of the cyclic AMP response element-binding protein pathway. Effects of long-term and acute treatments. Neuroendocrinology 74: 227-243.
150. Kelly MJ, Lagrange AH, Wagner EJ, Ronnekleiv OK, 1999 Rapid effects of estrogen to modulate G proteincoupled receptors via activation of protein kinase A and protein kinase C pathways. Steroids 64: 64-75.
151. Wagner EJ, Ronnekleiv OK, Kelly MJm 1998 Protein kinase A maintains cellular tolerance to mu opioid receptor agonists in hypothalamic neurosecretory cells with chronic morphine treatment: convergence on a common pathway with estrogen in modulating mu opioid receptor/effector coupling. J Pharmacol Exp Ther 285: 1266-1273.
152. Lagrange AH, Ronnekleiv OK, Kelly MJM, 1997 Modulation of G protein-coupled receptors by an estrogen receptor that activates protein kinase A. Mol Pharmacol 51: 605-612.
153. Van Dyke RW, Root KV, Hsi RA, 1996 cAMP and protein kinase A stimulate acidification of rat liver endosomes in the absence of chloride. Biochem Biophys Res Commun 222: 312-316.
154. Fujimoto N, Katzenellenbogen BS, 1994 Alteration in the agonist/antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: antiestrogen selectivity and promoter dependence. Mol Endocrinol 8: 296-304.
155. Davies WA, Berghorn KA, Albrecht ED, Pepe GJ, 1993 Developmental regulation of protein kinase-A and -C activities in the baboon fetal adrenal. Endocrinology 132: 2491-2497.
156. Filardo EJ, 2002 Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-proteincoupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer. J Steroid Biochem Mol Biol 80: 231-238.
157. Simstein R, Burow M, Parker A, Weldon C, Beckman B, 2003 Apoptosis, chemoresistance, and breast cancer: insights from the MCF-7 cell model system. Exp Biol Med (Maywood) 228: 995-1003.
158. Simoncini T, Mannella P, Fornari L, Caruso A, Varone G, Genazzani AR, 2004 Genomic and non-genomic effects of estrogens on endothelial cells. Steroids 69: 537-542.
159. Shupnik MA, 2004 Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: implications for cell proliferation. Oncogene 23: 7979-7989.
160. Kalkman HO, 2006 The role of the phosphatidylinositide 3-kinase-protein kinase B pathway in schizophrenia. Pharmacol Ther 110: 117-134.
161. Garcia-Segura LM, Sanz A, Mendez P, 2006 Crosstalk between IGF-I and estradiol in the brain: focus on neuroprotection. Neuroendocrinology 84: 275-279.
162. Cheskis BJ, Greger J, Cooch N, et al, 2008 MNAR plays an important role in ERa activation of Src/MAPK and PI3K/Akt signaling pathways. Steroids 73: 901-905.
163. Prossnitz ER, Oprea TI, Sklar LA, Arterburn JB, 2008 The ins and outs of GPR30: a transmembrane estrogen receptor. J Steroid Biochem Mol Biol 109: 350-353.
164. Fox EM, Andrade J, Shupnik MA, 2009 Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways. Steroids 74: 622-627.
165. Ma CX, Crowder RJ, Ellis MJ, 2011 Importance of PI3-kinase pathway in response/resistance to aromatase inhibitors. Steroids 76: 750-752.
166. Murphy E, 2011 Estrogen signaling and cardiovascular disease. Circ Res 109: 687-696.
167. Makker A, Goel MM, Das V, Agarwal A, 2012 PI3K-- Akt-mTOR and MAPK signaling pathways in polycystic ovarian syndrome, uterine leiomyomas and endometriosis: an update. Gynecol Endocrinol 28: 175-181.
168. Miller TW, Balko JM, Arteaga CL, 2011 Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancer. J Clin Oncol 29: 4452-4461.
169. Haynes MP, Li L, Sinha D, et al, 2003 Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen. J Biol Chem 278: 2118-2123.
170. Kampa M, Pelekanou V, Gallo D, et al, 2011 ERalpha17p, an ERalpha P295 -T311 fragment, modifies the migration of breast cancer cells, through actin cytoskeleton rearrangements. J Cell Biochem 112: 3786-3796.
171. Simoncini T, Rabkin E, Liao JK, 2003 Molecular basis of cell membrane estrogen receptor interaction with phosphatidylinositol 3-kinase in endothelial cells. Arterioscler Thromb Vasc Biol 23: 198-203.
172. Simoncini T, Varone G, Fornari L, et al, 2002 Genomic and nongenomic mechanisms of nitric oxide synthesis induction in human endothelial cells by a fourthgeneration selective estrogen receptor modulator. Endocrinology 143: 2052-2061.
173. Simoncini T, Fornari L, Mannella P, et al, 2002 Novel non-transcriptional mechanisms for estrogen receptor signaling in the cardiovascular system. Interaction of estrogen receptor alpha with phosphatidylinositol 3-OH kinase. Steroids 67: 935-939.
174. Pedram A, Razandi M, Aitkenhead M, Hughes CC, Levin ER, 2002 Integration of the non-genomic and genomic actions of estrogen. Membrane-initiated signaling by steroid to transcription and cell biology. J Biol Chem 277: 50768-50775.
175. Limbourg FP, Huang Z, Plumier JC, et al, 2002 Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J Clin Invest 110: 1729-1738.
176. Dos Santos EG, Dieudonne MN, Pecquery R, Le Moal V, Giudicelli Y, Lacasa D, 2002 Rapid nongenomic E2 effects on p42/p44 MAPK, activator protein-1, and cAMP response element binding protein in rat white adipocytes. Endocrinology 143: 930-940.
177. Santen RJ, Fan P, Zhang Z, Bao Y, Song RX, Yue W, 2009 Estrogen signals via an extra-nuclear pathway involving IGF-1R and EGFR in tamoxifen-sensitive and -resistant breast cancer cells. Steroids 74: 586-594.
178. Levin ER, 2003 Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor. Mol Endocrinol 17: 309-317.
179. Levin ER, 2002 Cellular functions of plasma membrane estrogen receptors. Steroids 67: 471-475.
180. Lichtner RB, 2003 Estrogen/EGF receptor interactions in breast cancer: rationale for new therapeutic combination strategies. Biomed Pharmacother 57: 447-451.
181. Kurebayashi J, Okubo S, Yamamoto Y, Sonoo H, 2004 Inhibition of HER1 signaling pathway enhances antitumor effect of endocrine therapy in breast cancer. Breast Cancer 11: 38-41.
182. Evinger AJ, 3rd, Levin ER, 2005 Requirements for estrogen receptor alpha membrane localization and function. Steroids 70: 361-363.
183. Gee JM, Robertson JF, Gutteridge E, et al, 2005 Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer. Endocr Relat Cancer 12: Suppl 1: 99-111.
184. Biswas DK, Iglehart JD, 2006 Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer. J Cell Physiol 209: 645-652.
185. Carreau S, Bois C, Zanatta L, Silva FR, Bouraima-Lelong H, Delalande C, 2011 Estrogen signaling in testicular cells. Life Sci 89: 584-587.
186. Bordeaux JM, Cheng H, Welsh AW, et al, 2012 Quantitative in situ measurement of estrogen receptor mRNA predicts response to tamoxifen. PLoS One 7: e36559.
187. Smith CL, Onate SA, Tsai MJ, O'Malley BW, 1996 CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptordependent transcription. Proc Natl Acad Sci U S A 93: 8884-8888.
188. Razandi M, Pedram A, Levin ER, 2000 Estrogen signals to the preservation of endothelial cell form and function. J Biol Chem 275: 38540-38546.
189. Wada-Hiraike O, Warner M, Gustafsson JA, 2006 New developments in oestrogen signalling in colonic epithelium. Biochem Soc Trans 34: 1114-1116.
190. Kampa M, Pelekanou V, Castanas E, 2008 Membraneinitiated steroid action in breast and prostate cancer. Steroids 73: 953-960.
191. Flamini MI, Sanchez AM, Goglia L, Tosi V, Genazzani AR, Simoncini T, 2009 Differential actions of estrogen and SERMs in regulation of the actin cytoskeleton of endometrial cells. Mol Hum Reprod 15: 675-685.
192. Flamini MI, Sanchez AM, Genazzani AR, Simoncini T, 2011 Estrogen regulates endometrial cell cytoskeletal remodeling and motility via focal adhesion kinase. Fertil Steril 95: 722-726.
193. Levin ER, 2011 Minireview: Extranuclear steroid receptors: roles in modulation of cell functions. Mol Endocrinol 25: 377-384.
194. (311)) exerts pro-apoptotic actions in breast cancer cells in vitro and in vivo, independently from their ERalpha status. Mol Oncol 5: 36-47.
195. Sanchez AM, Flamini MI, Polak K, et al, 2012 Actin cytoskeleton remodelling by sex steroids in neurones. J Neuroendocrinol 24: 195-201.
196. Sanchez AM, Flamini MI, Fu XD, et al, 2009 Rapid signaling of estrogen to WAVE1 and moesin controls neuronal spine formation via the actin cytoskeleton. Mol Endocrinol 23: 1193-1202.
197. Sanchez AM, Flamini MI, Baldacci C, Goglia L, Genazzani AR, Simoncini T, 2010 Estrogen receptor-alpha promotes breast cancer cell motility and invasion via focal adhesion kinase and N-WASP. Mol Endocrinol 24: 2114-2125.
198. Simoncini T, Scorticati C, Mannella P, et al, 2006 Estrogen receptor alpha interacts with Galpha13 to drive actin remodeling and endothelial cell migration via the RhoA/Rho kinase/moesin pathway. Mol Endocrinol 20: 1756-1771.
199. Giretti MS, Fu XD, De Rosa G, et al, 2008 Extranuclear signalling of estrogen receptor to breast cancer cytoskeletal remodelling, migration and invasion. PLoS One 3: e2238.
200. Kampa M, Nifli AP, Charalampopoulos I, et al, 2005 Opposing effects of estradiol- and testosterone-membrane binding sites on T47D breast cancer cell apoptosis. Exp Cell Res 307: 41-51.
201. Jacob J, Sebastian KS, Devassy S, et al, 2006 Membrane estrogen receptors: genomic actions and post transcriptional regulation. Mol Cell Endocrinol 246: 34-41.
202. Pelekanou V, Notas G, Sanidas E, Tsapis A, Castanas E, Kampa M, 2010 Testosterone membrane-initiated action in breast cancer cells: Interaction with the androgen signaling pathway and EPOR. Mol Oncol 4: 135-149.
203. Pelekanou V, Kampa M, Kafousi M, et al, 2007 Erythropoietin and its receptor in breast cancer: correlation with steroid receptors and outcome. Cancer Epidemiol Biomarkers Prev 16: 2016-2023.
204. Pelekanou V, Notas G, Kampa M, et al, 2012 ERalpha36, a new variant of the ERalpha is expressed in triple negative breast carcinomas and has a specific transcriptomic signature in breast cancer cell lines. Steroids 77: 928-934.
205. Zhang XT, Kang LG, Ding L, Vranic S, Gatalica Z, Wang ZY, 2011 A positive feedback loop of ER-alpha36/ EGFR promotes malignant growth of ER-negative breast cancer cells. Oncogene 30: 770-780.
206. Zhang X, Ding L, Kang L, Wang ZY, 2012 Estrogen receptor-alpha 36 mediates mitogenic antiestrogen signaling in ER-negative breast cancer cells. PLoS One 7: e30174.
207. Lee LM, Cao J, Deng H, Chen P, Gatalica Z, Wang ZY, 2008 ER-alpha36, a novel variant of ER-alpha, is expressed in ER-positive and -negative human breast carcinomas. Anticancer Res 28: 479-483.
208. Shi L, Dong B, Li Z, et al, 2009 Expression of ER-α36, a novel variant of estrogen receptor α, and resistance to tamoxifen treatment in breast cancer. J Clin Oncol 27: 3423-3429.
209. Welsh AW, Lannin DR, Young GS, et al, 2012 Cytoplasmic estrogen receptor in breast cancer. Clin Cancer Res 18: 118-126.
210. Martin PM, Sheridan PJ, 1986 Intracellular localization of steroid hormone receptors. A challenging problem. Autoradiographic and biochemical study. Ann Pathol 6: 115-119.
211. Seo HS, Larsimont D, Querton G, et al, 1998 Estrogenic and anti-estrogenic regulation of estrogen receptor in MCF-7 breast-cancer cells: comparison of immunocytochemical data with biochemical measurements. Int J Cancer 78: 760-765.